To assess the predictive significance of invasive FoxP3+ Tregs in patients with various subtypes of biliary tract cancer, a subgroup analysis was conducted specifically focusing on gallbladder carcinoma and cholangiocarcinoma (including intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma). This evidence concerns the gene FOXP3 and intrahepatic cholangiocarcinoma.